Cargando...
Discussing Cervical Cancer Screening Options: Outcomes to Guide Conversations Between Patients and Providers
Purpose. In 2018, the US Preventive Services Task Force (USPSTF) endorsed three strategies for cervical cancer screening in women ages 30 to 65: cytology every 3 years, testing for high-risk types of human papillomavirus (hrHPV) every 5 years, and cytology plus hrHPV testing (co-testing) every 5 yea...
Gardado en:
| Publicado en: | MDM Policy Pract |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
SAGE Publications
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7440733/ https://ncbi.nlm.nih.gov/pubmed/32885045 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2381468320952409 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|